Cargando…

Modeling of pulmonary deposition of agents of open and fixed dose triple combination therapies through two different low-resistance inhalers in COPD: a pilot study

INTRODUCTION: Inhalation therapy is a cornerstone of treating patients with chronic obstructive pulmonary disease (COPD). Inhaler devices might influence the effectiveness of inhalation therapy. We aimed to model and compare the deposition of acting agents of an open and a fixed dose combination (FD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erdelyi, Tamas, Lazar, Zsofia, Farkas, Árpád, Furi, Peter, Nagy, Attila, Müller, Veronika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196142/ https://www.ncbi.nlm.nih.gov/pubmed/37215734 http://dx.doi.org/10.3389/fmed.2023.1065072

Ejemplares similares

The effect of lung emptying before the inhalation of aerosol drugs on drug deposition in the respiratory system
por: Farkas, Árpád, et al.
Publicado: (2023)

Modeling of nursing care-associated airborne transmission of SARS-CoV-2 in a real-world hospital setting
por: Nagy, Attila, et al.
Publicado: (2022)

Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles
por: Madas, Balázs G., et al.
Publicado: (2020)

Simulation of Airway Deposition of an Aerosol Drug in COPD Patients
por: Farkas, Árpád, et al.
Publicado: (2019)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
por: López-Campos, José Luis, et al.
Publicado: (2020)

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD
por: Csoma, Balázs, et al.
Publicado: (2019)

Simulation of the effect of mucociliary clearance on the bronchial distribution of inhaled radon progenies and related cellular damage using a new deposition and clearance model for the lung
por: Farkas, Árpád
Publicado: (2020)

Impact of Clinical Factors on Generic and Disease-Specific Quality of Life in COPD and Asthma-COPD Overlap with Exacerbations
por: Lázár, Zsófia, et al.
Publicado: (2020)

Current appraisal of single inhaler triple therapy in COPD
por: Lipworth, Brian, et al.
Publicado: (2018)

Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD
por: Kim, Sae Ahm, et al.
Publicado: (2016)

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
por: Bourbeau, Jean, et al.
Publicado: (2021)

The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions
por: Farkas, Árpád, et al.
Publicado: (2023)

Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
por: D’Urzo, Anthony, et al.
Publicado: (2019)

The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
por: Dobler, Claudia C.
Publicado: (2018)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD
por: Naya, Ian, et al.
Publicado: (2018)

Erratum: Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD
Publicado: (2016)

The effect of oral and nasal breathing on the deposition of inhaled particles in upper and tracheobronchial airways
por: Lizal, Frantisek, et al.
Publicado: (2020)

Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simulations
por: Usmani, Omar S, et al.
Publicado: (2020)

Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
por: Resta, Emanuela, et al.
Publicado: (2022)

Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses
por: Csoma, Balázs, et al.
Publicado: (2021)

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
por: Halpin, David M.G., et al.
Publicado: (2018)

Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
por: Fenwick, Elisabeth, et al.
Publicado: (2021)

Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial
por: Martin, Alan, et al.
Publicado: (2022)

Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2020)

Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD
por: Prakash, Anoop, et al.
Publicado: (2015)

Open and Closed Triple Inhaler Therapy in Patients with Uncontrolled Asthma
por: Kotoulas, Serafeim-Chrysovalantis, et al.
Publicado: (2023)

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
por: Tabberer, Maggie, et al.
Publicado: (2020)

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
por: Ismaila, Afisi S, et al.
Publicado: (2019)

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
por: Halpin, David M.G., et al.
Publicado: (2021)

Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK
por: Kiff, Chris, et al.
Publicado: (2018)

Size distribution and relationship of airborne SARS-CoV-2 RNA to indoor aerosol in hospital ward environments
por: Groma, V., et al.
Publicado: (2023)

FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy
por: González-Torralba, Fernando, et al.
Publicado: (2022)

“All I want for Christmas is Two”: The Advent of Novel Fixed-Combination Inhalers for COPD and Outlook for 2014
por: Beeh, Kai M.
Publicado: (2013)

Asthma control and COPD symptom burden in patients using fixed-dose combination inhalers (SPRINT study)
por: Roche, Nicolas, et al.
Publicado: (2020)

Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England
por: Rothnie, Kieran J, et al.
Publicado: (2022)

Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
por: Paly, Victoria Federico, et al.
Publicado: (2022)

Handbook of Topological Fixed Point Theory
por: Brown, Robert F, et al.
Publicado: (2005)

A randomized, open-label, single-visit, crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD
por: van der Palen, Job, et al.
Publicado: (2018)

Matching the Inhaler to the Patient in COPD
por: Peché, Rudi, et al.
Publicado: (2021)

Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety
por: Suissa, Samy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8qi31dt8fbu0dqvjulfv4tic53